BC Week In Review | Jan 10, 2011
Clinical News

BD ProbeTec HSV-1 and HSV-2 Qx Amplified DNA Assays regulatory update

Becton said its BD Diagnostics segment submitted a 510(k) application to FDA for its BD ProbeTec HSV-1 and HSV-2 Qx Amplified DNA Assays to diagnose and differentiate patients with herpes simplex virus type 1 (HSV-1)...
Items per page:
1 - 1 of 1